Hepatitis C: Difference between revisions
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
m (Text replacement - "Category:Comorbidities" to "Category:Potential comorbidities") |
Notjusttired (talk | contribs) (tidy) |
||
| (3 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
'''Hepatitis C''' ('''HCV''' or '''Hep C''') is a disease caused by an [[RNA]] [[virus]] that affects approximately 170 million people worldwide<ref name="Siu2016" /> and is most often known for its associations with liver damage. | '''Hepatitis C''' ('''HCV''' or '''Hep C''') is a disease caused by an [[RNA]] [[virus]] that affects approximately 170 million people worldwide<ref name="Siu2016">{{citation | ||
| last1 = Siu | first1 = Gavin Ka Yu | authorlink1 = | |||
| last2 = Zhou | first2 = Fan | authorlink2 = | |||
| last3 = Yu | first3 = Mei Kuen | authorlink3 = | |||
| last4 = Zhang | first4 = Leiliang | authorlink4 = | |||
| last5 = Wang | first5 = Tuanlao | authorlink5 = | |||
| last6 = Liang | first6 = Yongheng | authorlink6 = | |||
| last7 = Chen | first7 = Yangchao | authorlink7 = | |||
| last8 = Chan | first8 = Hsiao Chang | authorlink8 = | |||
| last9 = Yu | first9 = Sidney | authorlink9 = | |||
| title = Hepatitis C virus NS5A protein cooperates with phosphatidylinositol 4-kinase IIIα to induce mitochondrial fragmentation | |||
| journal = Scientific Reports 6 | year = 2016 | | |||
| doi = 10.1038/srep23464 | |||
| url = http://www.nature.com/articles/srep23464 | |||
}}</ref> and is most often known for its associations with liver damage.<ref name="WHO2015">{{citation|title=Hepatitis C Fact sheet N°164|url=http://www.who.int/mediacentre/factsheets/fs164/en/|website=WHO|accessdate=4 February 2016|date=July 2015}}</ref> | |||
Hepatitis C incidence has been shown to be increased in [[chronic fatigue syndrome]] patients. | Hepatitis C incidence has been shown to be increased in [[chronic fatigue syndrome]] patients.{{citation needed|date=Jul 2020}} | ||
==Prevalence== | ==Prevalence== | ||
It is estimated that between 130-200 million people worldwide have a hepatitis C infection, occurring most commonly in Africa and Central and East Asia.<ref name="WHO2015" /> In 2013, hepatitis C was the cause of around 358,000 deaths due to cirrhosis and 343,000 deaths due to liver cancer.<ref name="GBD204" /> | It is estimated that between 130-200 million people worldwide have a hepatitis C infection, occurring most commonly in Africa and Central and East Asia.<ref name="WHO2015" /> In 2013, hepatitis C was the cause of around 358,000 deaths due to cirrhosis and 343,000 deaths due to liver cancer.<ref name="GBD204">{{citation|last1=GBD 2013 Mortality and Causes of Death|first1=Collaborators|title=Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013.|journal=Lancet|date=17 December 2014|pmid=25530442|doi=10.1016/S0140-6736(14)61682-2|volume=385|issue=9963|pages=117–71|pmc=4340604}}</ref> | ||
==Transmission== | ==Transmission== | ||
| Line 13: | Line 27: | ||
==Hepatitis C in Chronic Fatigue Syndrome== | ==Hepatitis C in Chronic Fatigue Syndrome== | ||
==Notable studies== | |||
==Potential treatments== | ==Potential treatments== | ||
==Learn more== | ==Learn more== | ||
*[ | *[http://www.who.int/mediacentre/factsheets/fs164/en/ Factsheet] - World Health Organization | ||
==See also== | |||
==References== | ==References== | ||
{{Reflist}} | |||
}} | |||
[[Category:Triggers and risk factors]] | [[Category:Triggers and risk factors]] | ||
| Line 47: | Line 46: | ||
[[Category:Potential comorbidities]] | [[Category:Potential comorbidities]] | ||
[[Category:Infectious diseases]] | [[Category:Infectious diseases]] | ||
[[Category:Viral diseases]] | |||
Revision as of 22:41, July 31, 2020
Hepatitis C (HCV or Hep C) is a disease caused by an RNA virus that affects approximately 170 million people worldwide[1] and is most often known for its associations with liver damage.[2]
Hepatitis C incidence has been shown to be increased in chronic fatigue syndrome patients.[citation needed]
Prevalence[edit | edit source]
It is estimated that between 130-200 million people worldwide have a hepatitis C infection, occurring most commonly in Africa and Central and East Asia.[2] In 2013, hepatitis C was the cause of around 358,000 deaths due to cirrhosis and 343,000 deaths due to liver cancer.[3]
Transmission[edit | edit source]
Signs and symptoms[edit | edit source]
Diagnosis[edit | edit source]
Hepatitis C in Chronic Fatigue Syndrome[edit | edit source]
Notable studies[edit | edit source]
Potential treatments[edit | edit source]
Learn more[edit | edit source]
- Factsheet - World Health Organization
See also[edit | edit source]
References[edit | edit source]
- ↑ Siu, Gavin Ka Yu; Zhou, Fan; Yu, Mei Kuen; Zhang, Leiliang; Wang, Tuanlao; Liang, Yongheng; Chen, Yangchao; Chan, Hsiao Chang; Yu, Sidney (2016), "Hepatitis C virus NS5A protein cooperates with phosphatidylinositol 4-kinase IIIα to induce mitochondrial fragmentation", Scientific Reports 6, doi:10.1038/srep23464 Cite has empty unknown parameter:
|1=(help) - ↑ 2.0 2.1 "Hepatitis C Fact sheet N°164", WHO, July 2015, retrieved February 4, 2016
- ↑ GBD 2013 Mortality and Causes of Death, Collaborators (December 17, 2014), "Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013.", Lancet, 385 (9963): 117–71, doi:10.1016/S0140-6736(14)61682-2, PMC 4340604, PMID 25530442
